CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION

Clinical trials for CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION trials appear

Sign up with your email to follow new studies for CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for devastating virus: cord blood transplant trial seeks to control rare blood disorders

Disease control Recruiting now

This study is testing whether a transplant using umbilical cord blood from an unrelated donor can effectively treat severe diseases caused by the Epstein-Barr virus (EBV). The trial will enroll 80 participants with specific EBV-related conditions that have not responded to standa…

Matched conditions: CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION

Get alerted when new CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION trials appear

New hope for devastating virus: cord blood transplant trial seeks to control rare blood disorders